Literature DB >> 31996461

Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.

Kyung-Jin Cho1, Satoshi Ishido2, Laurence C Eisenlohr3,4, Paul A Roche5.   

Abstract

Both immature and mature dendritic cells (DCs) can process and present foreign Ags to CD4 T cells; however, the mechanism by which MHC class II (MHC-II) in mature DCs acquires antigenic peptides remains unknown. To address this, we have studied Ag processing and presentation of two distinct CD4 T cell epitopes of the influenza virus hemagglutinin coat protein by both immature and mature mouse DCs. We find that immature DCs almost exclusively use newly synthesized MHC-II targeted to DM+ late endosomes for presentation to influenza virus-specific CD4 T cells. By contrast, mature DCs exclusively use recycling MHC-II that traffics to both early and late endosomes for antigenic peptide binding. Rab11a knockdown partially inhibits recycling of MHC-II in mature DCs and selectively inhibits presentation of an influenza virus hemagglutinin CD4 T cell epitope generated in early endosomes. These studies highlight a "division of labor" in MHC-II peptide binding, in which immature DCs preferentially present Ags acquired in Rab11a- DM+ late endosomes, whereas mature DCs use recycling MHC-II to present antigenic peptides acquired in both Rab11a+ early endosomes and Rab11a- endosomes for CD4 T cell activation.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31996461      PMCID: PMC7065958          DOI: 10.4049/jimmunol.1901234

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Developmental control of endocytosis in dendritic cells by Cdc42.

Authors:  W S Garrett; L M Chen; R Kroschewski; M Ebersold; S Turley; S Trombetta; J E Galán; I Mellman
Journal:  Cell       Date:  2000-08-04       Impact factor: 41.582

Review 2.  Endocytosis of influenza viruses.

Authors:  Melike Lakadamyali; Michael J Rust; Xiaowei Zhuang
Journal:  Microbes Infect       Date:  2004-08       Impact factor: 2.700

3.  Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells.

Authors:  Even Walseng; Kazuyuki Furuta; Berta Bosch; Karis A Weih; Yohei Matsuki; Oddmund Bakke; Satoshi Ishido; Paul A Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

4.  Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.

Authors:  Jeoung-Sook Shin; Melanie Ebersold; Marc Pypaert; Lelia Delamarre; Adam Hartley; Ira Mellman
Journal:  Nature       Date:  2006-10-08       Impact factor: 49.962

5.  Internalizing MHC class II-peptide complexes are ubiquitinated in early endosomes and targeted for lysosomal degradation.

Authors:  Kazuyuki Furuta; Even Walseng; Paul A Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

6.  T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes.

Authors:  Aura Muntasell; Adam C Berger; Paul A Roche
Journal:  EMBO J       Date:  2007-09-06       Impact factor: 11.598

7.  Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments.

Authors:  F Castellino; R N Germain
Journal:  Immunity       Date:  1995-01       Impact factor: 31.745

8.  Relaxed DM requirements during class II peptide loading and CD4+ T cell maturation in BALB/c mice.

Authors:  E K Bikoff; G Wutz; G A Kenty; C H Koonce; E J Robertson
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

9.  Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification.

Authors:  Gomathinayagam Sinnathamby; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

10.  Differential requirements for endosomal reduction in the presentation of two H2-E(d)-restricted epitopes from influenza hemagglutinin.

Authors:  Gomathinayagam Sinnathamby; Maja Maric; Peter Cresswell; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

View more
  5 in total

1.  Elucidating the Therapeutic Potential of Cell-Penetrating Peptides in Human Tenon Fibroblast Cells.

Authors:  Amit Chatterjee; Samdani Ansar; Divya Gopal; Umashankar Vetrivel; Ronnie George; Janakiraman Narayanan
Journal:  ACS Omega       Date:  2022-05-03

Review 2.  Importance of Efferocytosis in COVID-19 Mortality.

Authors:  Adnan Erol
Journal:  Infect Drug Resist       Date:  2022-03-10       Impact factor: 4.003

Review 3.  Activation of Cellular Players in Adaptive Immunity via Exogenous Delivery of Tumor Cell Lysates.

Authors:  Jihyun Seong; Kyobum Kim
Journal:  Pharmaceutics       Date:  2022-06-27       Impact factor: 6.525

4.  NKG2D Enhances Double-Negative T Cell Regulation of B Cells.

Authors:  Shi-Hua Hu; Long-Hui Zhang; Jie Gao; Jing-Heng Guo; Xiao-Dong Xun; Xiao Xiang; Qian Cheng; Zhao Li; Ji-Ye Zhu
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

Review 5.  Host-Virus Interaction: How Host Cells Defend against Influenza A Virus Infection.

Authors:  Yun Zhang; Zhichao Xu; Yongchang Cao
Journal:  Viruses       Date:  2020-03-29       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.